|
Name |
2-Ethyl-4-methylphenol
|
| Molecular Formula | C9H12O | |
| IUPAC Name* |
2-ethyl-4-methylphenol
|
|
| SMILES |
CCC1=C(C=CC(=C1)C)O
|
|
| InChI |
InChI=1S/C9H12O/c1-3-8-6-7(2)4-5-9(8)10/h4-6,10H,3H2,1-2H3
|
|
| InChIKey |
AVVVXUXMKWPKAJ-UHFFFAOYSA-N
|
|
| Synonyms |
2-Ethyl-4-methylphenol; 2-Ethyl-p-cresol; 3855-26-3; p-Cresol, 2-ethyl-; Phenol, 2-ethyl-4-methyl-; L4679W99NC; 2-ethyl-4-methyl-phenol; EINECS 223-361-8; UNII-L4679W99NC; 2-Ethyl-p-cresol, 8CI; SCHEMBL1023280; DTXSID30191879; ZINC5688568; 2-Ethyl-4-methylphenol, AldrichCPR; AKOS022633580; MB23622; CS-0237326; FT-0703977; EN300-182300; Q27282679
|
|
| CAS | 3855-26-3 | |
| PubChem CID | 77462 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 136.19 | ALogp: | 2.7 |
| HBD: | 1 | HBA: | 1 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 20.2 | Aromatic Rings: | 1 |
| Heavy Atoms: | 10 | QED Weighted: | 0.629 |
| Caco-2 Permeability: | -4.357 | MDCK Permeability: | 0.00002620 |
| Pgp-inhibitor: | 0.006 | Pgp-substrate: | 0.008 |
| Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.348 |
| 30% Bioavailability (F30%): | 0.878 |
| Blood-Brain-Barrier Penetration (BBB): | 0.584 | Plasma Protein Binding (PPB): | 90.77% |
| Volume Distribution (VD): | 1.59 | Fu: | 9.85% |
| CYP1A2-inhibitor: | 0.912 | CYP1A2-substrate: | 0.951 |
| CYP2C19-inhibitor: | 0.641 | CYP2C19-substrate: | 0.567 |
| CYP2C9-inhibitor: | 0.25 | CYP2C9-substrate: | 0.802 |
| CYP2D6-inhibitor: | 0.795 | CYP2D6-substrate: | 0.896 |
| CYP3A4-inhibitor: | 0.103 | CYP3A4-substrate: | 0.35 |
| Clearance (CL): | 14.167 | Half-life (T1/2): | 0.849 |
| hERG Blockers: | 0.015 | Human Hepatotoxicity (H-HT): | 0.036 |
| Drug-inuced Liver Injury (DILI): | 0.044 | AMES Toxicity: | 0.165 |
| Rat Oral Acute Toxicity: | 0.155 | Maximum Recommended Daily Dose: | 0.14 |
| Skin Sensitization: | 0.792 | Carcinogencity: | 0.289 |
| Eye Corrosion: | 0.972 | Eye Irritation: | 0.992 |
| Respiratory Toxicity: | 0.349 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000498 | ![]() |
0.636 | D06GIP | ![]() |
0.474 | ||
| ENC000329 | ![]() |
0.545 | D02ZJI | ![]() |
0.333 | ||
| ENC000172 | ![]() |
0.543 | D0K5CB | ![]() |
0.333 | ||
| ENC001026 | ![]() |
0.474 | D0T7OW | ![]() |
0.326 | ||
| ENC000413 | ![]() |
0.444 | D04PHC | ![]() |
0.319 | ||
| ENC000985 | ![]() |
0.421 | D0YF3X | ![]() |
0.315 | ||
| ENC000180 | ![]() |
0.417 | D0I8FI | ![]() |
0.314 | ||
| ENC000407 | ![]() |
0.405 | D07MOX | ![]() |
0.311 | ||
| ENC001052 | ![]() |
0.395 | D0S5LH | ![]() |
0.311 | ||
| ENC000552 | ![]() |
0.385 | D08HUC | ![]() |
0.309 | ||